Successful Osimertinib Rechallenge Under Systemic Corticosteroid Administration in EGFR T790M-positive Lung Adenocarcinoma After Osimertinib-induced Interstitial Lung Disease
Haigan · 20.04.2026 · 66 (2) · 60-65
DOI: 10.2482/haigan.66.60 ↗Kurz gefasst
Fachartikel in der Zeitschrift Haigan, erschienen am 20.04.2026. Verfasst von Mikako Tsuruta und 7 weiteren Autor:innen. Die Arbeit nennt 20 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Tsuruta, M., Nakashima, Y., Aoyagi, K., Hosoya, R., Ando, T., Nakagawa, A., Wakiya, M., & Noguchi, C. (2026). Successful Osimertinib Rechallenge Under Systemic Corticosteroid Administration in EGFR T790M-positive Lung Adenocarcinoma After Osimertinib-induced Interstitial Lung Disease. Haigan, 66(2), 60-65. https://doi.org/10.2482/haigan.66.60
Vancouver
Tsuruta M, Nakashima Y, Aoyagi K, Hosoya R, Ando T, Nakagawa A, et al. Successful Osimertinib Rechallenge Under Systemic Corticosteroid Administration in EGFR T790M-positive Lung Adenocarcinoma After Osimertinib-induced Interstitial Lung Disease. Haigan. 2026;66(2):60-65. doi:10.2482/haigan.66.60
BibTeX
@article{Tsuruta2026,
author = {Tsuruta, Mikako and Nakashima, Yasuhiro and Aoyagi, Kei and Hosoya, Ryusaku and Ando, Takahiro and Nakagawa, Atsushi and Wakiya, Midori and Noguchi, Chika},
title = {Successful Osimertinib Rechallenge Under Systemic Corticosteroid Administration in EGFR T790M-positive Lung Adenocarcinoma After Osimertinib-induced Interstitial Lung Disease},
journal = {Haigan},
year = {2026},
volume = {66},
number = {2},
pages = {60--65},
doi = {10.2482/haigan.66.60}
}
EUVIMED